Humana Inc Etf Analysis
| HUM Etf | USD 183.11 1.53 0.84% |
IPO Date 22nd of January 1993 | 200 Day MA 249.8538 | 50 Day MA 227.7264 | Beta 0.415 |
Humana Inc holds a debt-to-equity ratio of 0.852. Humana's financial risk is the risk to Humana stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Humana's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Humana's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the ETF is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Humana Etf's retail investors understand whether an upcoming fall or rise in the market will negatively affect Humana's stakeholders.
For many companies, including Humana, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Humana Inc, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Humana's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 1.2402 | Price Sales 0.1703 | Shares Float 120.3 M | Dividend Share 3.54 | Wall Street Target Price 223.875 |
Given that Humana's debt-to-equity ratio measures a ETF's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Humana is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Humana to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Humana is said to be less leveraged. If creditors hold a majority of Humana's assets, the ETF is said to be highly leveraged.
Humana Inc is undervalued with Real Value of 190.1 and Target Price of 223.88. The main objective of Humana etf analysis is to determine its intrinsic value, which is an estimate of what Humana Inc is worth, separate from its market price. There are two main types of Humana Etf analysis: fundamental analysis and technical analysis.
The Humana etf is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Humana Inc. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. Humana Etf Analysis Notes
The fund retains all of the assets under management (AUM) in different types of exotic instruments. Humana Inc last dividend was 3.54 per share. Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 95500 people. To learn more about Humana Inc call Bruce Broussard at 502 580 1000 or check out https://www.humana.com.Humana Inc Investment Alerts
| Humana Inc generated a negative expected return over the last 90 days | |
| Humana Inc has high historical volatility and very poor performance | |
| Over 100.0% of the company shares are owned by institutional investors | |
| On 30th of January 2026 Humana paid $ 0.885 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Talkspace Q4 2025 Earnings Call Transcript | |
| The fund retains all of the assets under management (AUM) in different types of exotic instruments |
Humana Market Capitalization
The company currently falls under 'Large-Cap' category with a total capitalization of 22.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Humana's market, we take the total number of its shares issued and multiply it by Humana's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Humana Profitablity
The company has Net Profit Margin of 0.01 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.02) %, which entails that for every $100 of revenue, it lost $0.02.Management Efficiency
Humana Inc has Return on Asset of 0.043 % which means that on every $100 spent on assets, it made $0.043 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0704 %, implying that it generated $0.0704 on every 100 dollars invested. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities.Humana Inc benefits from a management team that prioritizes both innovation and efficiency. We analyze these priorities to gauge the stock's future performance.
Institutional Etf Holders for Humana
Have you ever been surprised when a price of an equity instrument such as Humana is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Humana Inc backward and forwards among themselves. Humana's institutional investor refers to the entity that pools money to purchase Humana's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| NQGCX | Nuveen Nwq Global | Mutual Fund | World Large-Stock Value | |
| JAGLX | Janus Global Life | Mutual Fund | Health | |
| GPTUX | Guidepath Tactical Allocation | Mutual Fund | Tactical Allocation | |
| VPRAX | Voya T Rowe | Mutual Fund | Allocation--50% to 70% Equity | |
| HLGE | Hartford Funds | Etf | Mid-Cap Blend | |
| PHSZX | Prudential Health Sciences | Mutual Fund | Health | |
| JECTX | Janus Henderson Global | Mutual Fund | World Large-Stock Growth | |
| JEUIX | Janus Henderson Global | Mutual Fund | World Large-Stock Growth |
Humana Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Humana insiders, such as employees or executives, is commonly permitted as long as it does not rely on Humana's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Humana insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Raquel Bono over two months ago Acquisition by Raquel Bono of 766 shares of Humana subject to Rule 16b-3 | ||
Raquel Bono over two months ago Acquisition by Raquel Bono of tradable shares of Humana subject to Rule 16b-3 | ||
Smith Gordon over three months ago Acquisition by Smith Gordon of 765 shares of Humana subject to Rule 16b-3 | ||
Sam Deshpande over six months ago Disposition of 160 shares by Sam Deshpande of Humana at 271.675 subject to Rule 16b-3 | ||
David Feinberg over six months ago Acquisition by David Feinberg of tradable shares of Humana subject to Rule 16b-3 | ||
Celeste Mellet over a year ago Insider Trading | ||
O'hara Michelle A. over a year ago Insider Trading | ||
Smith Brad D over a year ago Acquisition by Smith Brad D of tradable shares of Humana subject to Rule 16b-3 | ||
Raquel Bono over a year ago Acquisition by Raquel Bono of tradable shares of Humana subject to Rule 16b-3 | ||
Renaudin George Ii over a year ago Acquisition by Renaudin George Ii of 1241 shares of Humana subject to Rule 16b-3 |
Humana Outstanding Bonds
Humana issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Humana Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Humana bonds can be classified according to their maturity, which is the date when Humana Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| HUMANA INC 395 Corp BondUS444859BF87 | View | |
| HUMANA INC 48 Corp BondUS444859BG60 | View | |
| HUMANA INC 495 Corp BondUS444859BE13 | View | |
| HUMANA INC 4625 Corp BondUS444859BB73 | View | |
| US444859BL55 Corp BondUS444859BL55 | View | |
| US444859BN12 Corp BondUS444859BN12 | View | |
| US444859BK72 Corp BondUS444859BK72 | View | |
| HUM 55 15 MAR 53 Corp BondUS444859BX93 | View |
Humana Predictive Daily Indicators
Humana intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Humana etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Humana Forecast Models
Humana's time-series forecasting models are one of many Humana's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Humana's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Humana Inc Debt to Cash Allocation
Many companies such as Humana, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Humana Inc has 12.37 B in debt with debt to equity (D/E) ratio of 0.85, which is OK given its current industry classification. Humana Inc has a current ratio of 1.5, which is typical for the industry and considered as normal. Debt can assist Humana until it has trouble settling it off, either with new capital or with free cash flow. So, Humana's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Humana Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Humana to invest in growth at high rates of return. When we think about Humana's use of debt, we should always consider it together with cash and equity.Humana Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Humana's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Humana, which in turn will lower the firm's financial flexibility.Humana Corporate Bonds Issued
Humana issues bonds to finance its operations. Corporate bonds make up one of the most significant components of the U.S. bond market and are considered the world's largest securities market. Humana Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt.
About Humana Etf Analysis
Etf analysis is the technique used by a trader or investor to examine and evaluate how Humana prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Humana shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as Humana. By using and applying Humana Etf analysis, traders can create a robust methodology for identifying Humana entry and exit points for their positions.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 95500 people.
Current Humana Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Humana analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Humana analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 223.88 | Buy | 26 | Odds |
Most Humana analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Humana stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Humana Inc, talking to its executives and customers, or listening to Humana conference calls.
Humana Etf Analysis Indicators
Humana Inc etf analysis indicators help investors evaluate how Humana etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Humana shares will generate the highest return on investment. By understating and applying Humana etf analysis, traders can identify Humana position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 2.2 B | |
| Long Term Debt | 12.4 B | |
| Common Stock Shares Outstanding | 120.8 M | |
| Total Stockholder Equity | 17.7 B | |
| Total Cashflows From Investing Activities | 2.3 B | |
| Tax Provision | 250 M | |
| Quarterly Earnings Growth Y O Y | -0.593 | |
| Property Plant And Equipment Net | 2.2 B | |
| Cash And Short Term Investments | 19.9 B | |
| Cash | 4.2 B | |
| Accounts Payable | 10 B | |
| Net Debt | 8.2 B | |
| 50 Day M A | 227.7264 | |
| Total Current Liabilities | 16.3 B | |
| Other Operating Expenses | 128.2 B | |
| Non Current Assets Total | 16.2 B | |
| Forward Price Earnings | 16.9205 | |
| Non Currrent Assets Other | 3.8 B | |
| Stock Based Compensation | 241 M |
Other Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.